Evaluation of Retinal and Vascular Features in Coats Disease After Intravitreal Injections of Ranibizumab

NCT04310631 · clinicaltrials.gov ↗

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Coats Disease

Interventions

DRUG: Ranibizumab Injection

Sponsor

Federico II University